Logical Therapeutics Lands $16,900,000 Series C Funding

  • Feed Type
  • Date
  • Company Name
    Logical Therapeutics
  • Mailing Address
    300 Second Avenue Waltham, MA 02451
  • Company Description
    The Company is developing medicines to treat diseases that are associated with poorly controlled or excessive inflammation.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    The Series C financing round is expected to provide sufficient capital to advance the Company’s development program through further clinical and non-clinical activities necessary for registration. The Company intends to seek a business partner prior to commercialization.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Burrill & Company
  • Venture Investor
    Novo A/S
  • Venture Investor
    Novitas Capital

Trending on Xconomy